These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27678498)

  • 21. A machine learning approach using auditory odd-ball responses to investigate the effect of Clozapine therapy.
    Ravan M; Hasey G; Reilly JP; MacCrimmon D; Khodayari-Rostamabad A
    Clin Neurophysiol; 2015 Apr; 126(4):721-30. PubMed ID: 25213349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
    Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
    Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonic transit diagnostic test shows significant gastrointestinal hypomotility in clozapine-treated patients in comparison with subjects treated with other antipsychotics.
    Baptista T; Carrizo E; Fernandez E; Connell L; Servigna M; Parra A; Quintero J; Pabón A; Sandia I; Uzcáteguid E; Serrano A; Pirela N; Villarreal L
    Schizophr Res; 2015 Aug; 166(1-3):207-11. PubMed ID: 26032569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia.
    Nakata Y; Kanahara N; Kimura H; Watanabe H; Iyo M
    Int Clin Psychopharmacol; 2017 May; 32(3):169-173. PubMed ID: 28067751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
    Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
    Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.
    Carrillo JA; Herraiz AG; Ramos SI; Benítez J
    J Clin Psychopharmacol; 1998 Aug; 18(4):311-6. PubMed ID: 9690697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic predictors for mortality among patients treated with long-term clozapine - A longitudinal study.
    Taub S; Hoshen M; Balicer R; Kamhi-Nesher S; Weizman A; Krivoy A
    Eur Neuropsychopharmacol; 2020 Dec; 41():63-69. PubMed ID: 32981820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the 'real world'.
    Pai NB; Laidlaw M; Vella SC
    Acta Psychiatr Scand; 2012 Jul; 126(1):40-6. PubMed ID: 22432694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent tachycardia in clozapine treated patients: A 24-hour ambulatory electrocardiogram study.
    Nilsson BM; Lindström L; Mohsen I; Holmlöv K; Bodén R
    Schizophr Res; 2018 Sep; 199():403-406. PubMed ID: 29602642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
    Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
    Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sequence in prescribing neuroleptics: a therapeutic alternative in refractory schizophrenia?].
    Allouche G; Joober R; Vanelle JM; Brochier T; Olié JP
    Encephale; 1994; 20(6):777-80. PubMed ID: 7875112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis.
    Ortega-Vázquez A; Mayen-Lobo YG; Dávila-Ortiz de Montellano DJ; Tristán-López L; Aviña-Cervantes CL; Ríos C; López-López M; Monroy-Jaramillo N
    Drug Dev Res; 2021 Aug; 82(5):685-694. PubMed ID: 33336447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Astroglial Connexin is Involved in Concentration-Dependent Double-Edged Sword Clinical Action of Clozapine.
    Fukuyama K; Okubo R; Murata M; Shiroyama T; Okada M
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.
    Havaki-Kontaxaki BJ; Ferentinos PP; Kontaxakis VP; Paplos KG; Soldatos CR
    Clin Neuropharmacol; 2006; 29(1):52-6. PubMed ID: 16518135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating Predictors of Clozapine Response in Adolescents with Schizophrenia and Schizoaffective Disorder.
    Karacetin G; Ermis C; Bulanik Koc E; Saglam Y
    J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):504-510. PubMed ID: 34283936
    [No Abstract]   [Full Text] [Related]  

  • 36. Clozapine pharmacogenomics: a review of efficacy, pharmacokinetics, and agranulocytosis.
    Li KJ; Solomon HV; DeLisi LE
    Curr Opin Psychiatry; 2018 Sep; 31(5):403-408. PubMed ID: 29985178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.
    Birkenaes AB; Birkeland KI; Engh JA; Faerden A; Jonsdottir H; Ringen PA; Friis S; Opjordsmoen S; Andreassen OA
    J Clin Psychopharmacol; 2008 Apr; 28(2):132-7. PubMed ID: 18344722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on.
    Gahr M; Rehbaum K; Connemann BJ
    Pharmacopsychiatry; 2014 May; 47(3):118-20. PubMed ID: 24846087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.